Tirzepatide has emerged as a groundbreaking treatment for type 2 diabetes, offering promising results. However, the cost of this innovative drug and its access have become key topics for patients and healthcare professionals. While tirzepatide has been cleared by regulatory agencies, its costly nature presents a significant obstacle to many. Negot